Estamos atentos a atual pandemia do novo Coronavírus – COVID -19 e suas consequências no Brasil e no exterior. Visando preservar a saúde e bem-estar de todos os participantes do congresso e da comunidade em geral, informamos que o XXIX Congresso Brasileiro de Neurologia terá sua realização alterada para 05 a 08 de setembro de 2021.
Cientes que a atualização e o debate científico são fundamentais neste momento, a Academia Brasileira de Neurologia promoverá dias 29 e 30 de agosto de 2020 um evento digital que será uma prévia do que ocorrerá em Gramado em 2021. Fique atento aos nossos comunicados que, em breve, divulgaremos mais informações sobre o programa e demais detalhes do evento online.
Queremos reforçar nosso compromisso com toda a comunidade que prestigia o Congresso, dessa forma, enviamos abaixo algumas informações referentes a tal alteração:
Inscrições – Para todos que já realizaram e efetuaram o pagamento da inscrição, a participação no evento em 2021 está confirmada. Caso não possam participar do evento na nova data, a taxa de inscrição será reembolsada integralmente. Os participantes que mantiverem sua inscrição para nova data do evento, ganharão isenção no evento digital. Caso tenha alguma dúvida sobre inscrições escreva para: email@example.com
Hospedagem - Quem comprou hospedagem com a agência oficial (MFM) terá sua hospedagem remanejada para o novo período ou reembolsada, caso não possa participar. Em caso de dúvidas sobre sua reserva de hotel escreva para: firstname.lastname@example.org
Palestrantes - Pretendemos manter a participação dos convidados internacionais já anunciados, tanto no evento digital como no presencial em 2021. Dúvidas em relação ao programa e palestrantes: email@example.com
Trabalhos científicos – Todos os trabalhos científicos que foram submetidos até o momento serão mantidos para a edição online do evento. Caso os autores não possam participar e cancelem suas inscrições, terão seus trabalhos automaticamente desconsiderados. Caso tenha alguma dúvida sobre trabalhos contate firstname.lastname@example.org
Neste momento, suspendemos temporariamente a possibilidade de pagamento de inscrição antecipada, bem como a compra de hospedagem pelo site. Tão logo as inscrições sejam reabertas, informaremos em todos os canais oficiais de divulgação do Congresso.
Seguiremos atentos e estamos à disposição no caso de dúvidas através do FALE CONOSCO.
Diretoria do XXIX Congresso Brasileiro de Neurologia – Gramado
Presidente Do Congresso:
Dr. Carlos Roberto de Mello Rieder
Dr. Francisco Tellechea Rotta
Dr. Fernando Kowacs
acesse AQUI O SITE DO NEURO2021
Adrian Raine is the Richard Perry University Professor of Criminology, Psychiatry, and Psychology at the University of Pennsylvania. His research focuses on the etiology and prevention of antisocial, criminal, and psychopathic behavior in children and adults. His latest book, The Anatomy of Violence (2013, Pantheon and Penguin), reviews the brain basis to violence. He is past-President of the Academy of Experimental Criminology, and received an honorary degree from the University of York (UK) in 2015.
Avshalom Caspi, Ph.D., is the Edward M. Arnett Professor of Psychology & Neuroscience at Duke University, and Professor of Personality Development at the Institute of Psychiatry, Psychology, & Neuroscience, King’s College London. His expertise is in longitudinal methods, developmental psychology, personality assessment, life-course epidemiology, and genomics in behavioral science.
Professor Bas Bloem is a consultant neurologist at the Department of Neurology, Radboud University Nijmegen Medical Centre, the Netherlands. In September 2008, Professor Bloem was appointed as Professor of Neurology, with movement disorders as special area of interest. He has published over 550 publications, including over 400 peer‐reviewed international papers.
Daniela Perani, MD, is a Neurologist and Radiologist and Full Professor of Neuroscience at Università Vita-Salute San Raffaele. She the director of the School of Specialization in Neuropsychology in the same university and Chief Coordinator of Nuclear Medicine Neurology, in the Nuclear Medicine Unit, at IRCCS Ospedale San Raffaele. She Head of Unit in the Division of Neuroscience of IRCCS Ospedale San Raffaele and Coordinator of several National and International Research Projects in Neurology and Neuroscience. Her researches deal with in vivo neuroimaging studies of neurological disease, in particular neurodegenerative dementias, and with cognitive neuroscience.
George I. Papakostas is Associate Professor of Psychiatry at Harvard Medical School and Director of Treatment-Resistant Depression Studies in the Department of Psychiatry at Massachusetts General Hospital in Boston, Massachusetts. He is also field editor for Psychopharmacology for the World Journal of Biological Psychiatry and on the editorial board of the journal Psychiatry Research. The focus of Dr Papakostas research includes the pharmacotherapy of major depressive disorder (MDD) including treatment-resistant depression, the study of the placebo effect and its relevance to clinical trial design in MDD, and the study of clinical and biologic markers of treatment outcome in MDD.
Dr. Hallett obtained his A.B. and M.D. at Harvard University, had his internship in Medicine at the Peter Bent Brigham Hospital and his Neurology training at Massachusetts General Hospital. He had fellowships in neurophysiology at the NIH and in the Department of Neurology, Institute of Psychiatry in London, where he worked with C. David Marsden. Before coming to NIH in 1984, Dr. Hallett was the Chief of the Clinical Neurophysiology Laboratory at the Brigham and Women‘s Hospital in Boston and progressed to Associate Professor of Neurology at Harvard Medical School. He is currently Chief of the Medical Neurology Branch and Chief of its Human Motor Control Section. He is now Past-President of the International Federation of Clinical Neurophysiology. He has been President of the International Parkinson and Movement Disorder Society and Vice-President of the American Academy of Neurology. He served as Editor in Chief of Clinical Neurophysiology. Among many awards, in 2012 he became an Honorary Member of the American Neurological Association, and in 2014 won the Lifetime Achievement Award of the American Association of Neuromuscular and Electrodiagnostic Medicine. In 2017 he received the degree of Doctor of Medicine Honoris Causa from the University of Hamburg, and in 2018 was made an Honorary Member of the European Academy of Neurology. His research activities focus on the physiology of human voluntary movement and its pathophysiology in disordered voluntary movement and involuntary movement.
Professor Stefano F. Cappa graduated in Medicine and specialized in Neurology at the University of Milan. He has spent periods of study and research at the University of Boston, the Massachusetts Institute of Technology, the Medical Research Council Cyclotron Unit of Hammersmith Hospital in London, and the Max Planck Institute for Cognitive Neuroscience in Leipzig. Since 1999 full professor of Cognitive Neuroscience at the University Vita-Salute S. Raffaele of Milan, and Director of the Unit of Neuroriabilitation of San Raffaele Turro, since 2013 professor of neurology at the IUSS of Pavia. From 2016 to 2019 Scientific Director of the IRCCS S. Giovanni di Dio Fatebenefratelli, Brescia, from 2019 affiliated to the Institute of Neurology, Mondino Foundation. Prof. Cappa‘s research activity is in the area of cognitive neurosciences, and concerns in particular the neurological bases of language, memory and social behaviour. He has published more than 350 papers in leading international neurological and neuropsychological journals, and several books, including recently "Cognitive Neurology" at Oxford University Press.
Dr. Stahl iss professor at the University of California at San Diego and Honorary Fellow in Psychiatry at the University of Cambridge, editor-in-chief of CNS Spectrums and author of over 500 articles and chapters, and more than 1600 scientific presentations and abstracts, and 52 textbooks including the best selling Stahl’s Essential Psychopharmacology, now in its fourth edition and the best selling and award winning clinical manual, Essential Psychopharmacology Prescriber’s Guide, now in its sixth edition. His books have won the British Medical Association’s Book of the Year Award and recently, first prize for best digital medical book. Recently, Dr. Stahl has published his first novel, Shell Shock , a thriller that recounts the history of PTSD (post traumatic stress disorder). Dr. Stahl has been awarded the International College of Neuropsychopharmacology (CINP) Lundbeck Foundation Award in Education, the A.E. Bennett Award of the Society of Biological Psychiatry, the APA/San Diego Psychiatric Society Education Award, the UCSD Psychiatry Residency Teaching Award, has been cited as both one of “America’s Top Psychiatrists” and one of the “Best Doctors in America” and was honored with the Distinguished Psychiatrist Award of the APA and gave the Distinguished Psychiatrist Lecturer for 2013 and later the 2016 David Mrazek Award Winner of the American Psychiatric Association and gave the Mrazek Pharmacogenomics Memorial Lecture at the 2016 APA meeting.
Terrie E. Moffitt, Ph.D., is the Nannerl O. Keohane University Professor of Psychology at Duke University, and Professor of Social Development at King’s College London. Her expertise is in the areas of longitudinal methods, developmental theory, clinical mental health research, neuropsychology, and genomics in behavioral science. Her initial interest was in antisocial and criminal behavior, but she also studies depression, psychosis, and addiction. She is interested in the consequences of a lifetime of mental and behavioral disorder on processes of aging.